Skip to Main Content

Author Details

John K Parsons
university of california san diego Moores Cancer Center
2001
183
48
PMIDPaper TitleJournal TitlePublished Year
36517408A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance.Eur Urol Focus2023
34267333The microbiome and prostate cancer.Prostate Cancer Prostatic Dis2022
35488122Correction: Germline alterations among Hispanic men with prostate cancer.Prostate Cancer Prostatic Dis2022
35130495Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance.J Natl Compr Canc Netw2022
35228665Germline alterations among Hispanic men with prostate cancer.Prostate Cancer Prostatic Dis2022
34893859Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer.J Natl Cancer Inst2022
34806168Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.Cancer2022
33999164Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance.JAMA Netw Open2021
35492227Impact of age on treatment response in men with prostate cancer treated with radiotherapy.BJUI Compass2021
33683939Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer.J Urol2021
33780276Baseline Testosterone Levels in Men with Clinically Localized High-Risk Prostate Cancer Treated with Radical Prostatectomy with or without Neoadjuvant Chemohormonal Therapy (Alliance).J Urol2021
34347291Active surveillance for intermediate-risk prostate cancer in African American and non-Hispanic White men.Cancer2021
34269808Evaluation of Insurance Coverage and Cancer Stage at Diagnosis Among Low-Income Adults With Renal Cell Carcinoma After Passage of the Patient Protection and Affordable Care Act.JAMA Netw Open2021
32513967Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease.Prostate Cancer Prostatic Dis2020
31935026Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial.JAMA2020
31734020Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group.Urol Oncol2020
32573663Vegetable Consumption and Progression of Prostate Cancer-Reply.JAMA2020
32706639Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer.J Clin Oncol2020
32698710Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2020.J Urol2020
32327702African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance.Prostate Cancer Prostatic Dis2020
32516092Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.J Clin Oncol2020
30543857Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer.Int J Radiat Oncol Biol Phys2019
31387962Guidelines should be assessed based on the underlying evidence.CMAJ2019
31626312Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults.JAMA Netw Open2019
31629425Germline testing in those at risk of prostate cancer.Can J Urol2019
31504596Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial.J Clin Endocrinol Metab2019
31059668Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019.J Urol2019
31058923Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer.JAMA Intern Med2019
30930098Urological cancers and lifestyle: Nudging patients toward healthy behaviors.Urol Oncol2019
29321194Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.BMJ2018
30081846The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.BMC Cancer2018
30197041A Randomized, Double-blind, Phase II Trial of PSA-TRICOM (PROSTVAC) in Patients with Localized Prostate Cancer: The Immunotherapy to Prevent Progression on Active Surveillance Study.Eur Urol Focus2018
28437029Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer.BJU Int2018
29775639Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline.J Urol2018
29076872Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: Comparison and Ranking of T1 Quantification Approaches to Predict Progression to Muscularis Propria Invasion.Am J Surg Pathol2018
29049045Nutrition, physical activity, and lifestyle factors in prostate cancer prevention.Curr Opin Urol2018
27527500Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.J Magn Reson Imaging2017
28113060Surgical Options for the Enlarged, Obstructing, Benign Prostate.J Urol2017
29556580Salvage image guided radiation therapy to the prostate after cryotherapy failure.Adv Radiat Oncol2017
29234262Physical Activity Decreases Kidney Cancer Mortality.Curr Urol2017
29281666Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.PLoS One2017
27769917Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review?Urology2017
28007367Exercise Decreases and Smoking Increases Bladder Cancer Mortality.Clin Genitourin Cancer2017
26754261In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.Prostate Cancer Prostatic Dis2016
28723378Dietary Antioxidants and Longitudinal Changes in Lower Urinary Tract Symptoms in Elderly Men: The Osteoporotic Fractures in Men Study.Eur Urol Focus2016
266140274-Kallikrein Test and Kallikrein Markers in Prostate Cancer Screening.Urol Clin North Am2016
27476131Robotic-Assisted Simple Prostatectomy: An Overview.Urol Clin North Am2016
27355400Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels.J Clin Endocrinol Metab2016
27160230NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.J Natl Compr Canc Netw2016
27250935Voxel Level Radiologic-Pathologic Validation of Restriction Spectrum Imaging Cellularity Index with Gleason Grade in Prostate Cancer.Clin Cancer Res2016
  • 1 - 50 of 183

Recommended Authors

Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year 2013
Number of shared co-authors 7
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 10
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 4
University of Oxford
Career Start Year 2007
Number of shared co-authors 8
University of Alberta
Career Start Year 2007
Number of shared co-authors 7
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2005
Number of shared co-authors 27
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 19
University of California San Diego
Career Start Year 2005
Number of shared co-authors 4
New York Presbyterian Hospital-Weill Cornell
Career Start Year 2004
Number of shared co-authors 1
Bristol Urological Institute, Southmead Hospital
Career Start Year 2004
Number of shared co-authors 8
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 16
University of Washington School of Medicine
Career Start Year 2001
Number of shared co-authors 22
Northwestern University Feinberg School of Medicine
Career Start Year 1999
Number of shared co-authors 40
Weill Cornell Medical Center
Career Start Year 1998
Number of shared co-authors 17
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 12
Queen's University
Career Start Year 1996
Number of shared co-authors 7
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 38
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 8
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 3
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 8
Yonsei University College of Medicine and Gangnam Severance Hospital
Career Start Year 1992
Number of shared co-authors 10
Hospitalier Universitaire de Saint-Etienne
Career Start Year 1989
Number of shared co-authors 25
University of Melbourne
Career Start Year 1988
Number of shared co-authors 1
Monash University
Career Start Year 1988
Number of shared co-authors 23
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 5
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 12
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 26
Mayo Clinic
Career Start Year 1980
Number of shared co-authors 4
Royal Melbourne Hospital
Career Start Year 1974
Number of shared co-authors 9
University of Toronto, University Health Network
Career Start Year 1971
Number of shared co-authors 10

Collaborators

Hunter Medical Research Institute
Co-authored papers 19
University of Texas Health San Antonio
Co-authored papers 11
University of California San Diego
Co-authored papers 8
University of California San Diego School of Medicine
Co-authored papers 8
University of California San Diego Moores Cancer Center
Co-authored papers 8
university of california san diego School of Medicine
Co-authored papers 8
University of California
Co-authored papers 7
Haukeland University Hospital
Co-authored papers 7
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 7
Weill Cornell Medical College
Co-authored papers 6
University of California San Francisco
Co-authored papers 6
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers 6
Co-authored papers 5
CHRISTUS Santa Rosa Hospital-Medical Center
Co-authored papers 5
Herbert Wertheim School of Public Health, University of California San Diego
Co-authored papers 5
University of Virginia
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Herbert Wertheim School of Public Health, University of California
Co-authored papers 4
Co-authored papers 4
Cedars-Sinai Medical Center
Co-authored papers 4
School of Public Health, University of Pittsburgh
Co-authored papers 4
University of Michigan ann arbor
Co-authored papers 4
University of California san francisco
Co-authored papers 4
David Geffen School of Medicine at university of california los angeles
Co-authored papers 3
Institute on Aging, University of Florida
Co-authored papers 3
University of California
Co-authored papers 3
Invitae Corporation
Co-authored papers 3
School of Public Health, Oregon Health & Science University-Portland State University
Co-authored papers 3
Co-authored papers 3
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 3